Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5G1L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,546
Award facts
- Contract value 100% obligated
- $17,545.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On February 4, 2026, the Defense Logistics Agency awarded a delivery order valued at $17,545.78 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens (2 ml). This firm fixed-price, non-set-aside contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical position in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company demonstrates extensive capability in fulfilling federal pharmaceutical needs across multiple therapeutic domains through competitively awarded contracts with the DLA Medical Supply Chain. This delivery order for Dupixent, a biologic medication used for conditions such as eczema and asthma, reflects the company's continued role in supplying specialized pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F5G1L?
SPE2DR26F5G1L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F5G1L worth?
The government has obligated $17,546 on SPE2DR26F5G1L.
Is contract SPE2DR26F5G1L an order under another contract?
Yes. SPE2DR26F5G1L is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5G1L competed?
The extent of competition for SPE2DR26F5G1L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award